Fielmann: Growth ambitions by 2030 - Expansion in Europe and the USA as well as the teleophthalmology platform are set to improve revenue by 60%!

Among the high-quality companies, the stock of Fielmann (WKN 577220) is particularly interesting, being only 0.8% away from its 52-week high. Traders are watching for a potential breakout to the 52-week high! In the first half of the year, revenue grew by 12% to €1.2 billion. EBITDA increased by 26% to €290 million, which improved the margin from 21.1% to 23.7%. Fielmann attributed this to an improved sales structure, productivity gains, and cost efficiency. By 2030, the company has ambitious targets. Revenue is expected to increase from €2.5...